Stock Comparison
BNTX vs VRTX
BioNTech SE and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$23.07B
$124.70B
P/E (TTM)
—
29.2
Forward P/E
7.0
25.8
Price/Sales
8.2
10.2
Price/Book
1.0
6.4
EV/EBITDA
32.7
24.0
Dividend Yield
—
—
Profitability
Net Margin
-44.60%
35.50%
Operating Margin
-577.00%
38.10%
Return on Equity
-6.66%
24.20%
Return on Assets
-4.18%
12.10%
Growth (YoY)
Revenue Growth
-35.40%
7.80%
Earnings Growth
-43.20%
61.40%
Price & Risk
Beta
1.3
0.3
52-Week High
$124.00
$507.92
52-Week Low
$79.52
$362.50
Analyst Target
$121.59
$548.69
Compare BNTX and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.